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Vaccinethe reassortment of genes have been considered as the key factors responsible
for inﬂuenza A virus virulence and host tropism change. This study reports several signiﬁcant evidence
demonstrating that homologous recombination also takes place between inﬂuenza A viruses in human and
swine lineages. Moreover, in a mosaic descended from swine H1N1 subtype and human H2N2, we found that
its minor putative parent might be a derivative from the human cold-adapted vaccine lineage, which
suggests that live vaccine is capable of playing a role in genetic change of inﬂuenza A virus via recombination
with circulating viruses. These results would be important for knowing the molecular mechanism of
mammal inﬂuenza A virus heredity and evolution.
© 2008 Elsevier Inc. All rights reserved.IntroductionInﬂuenza viruses threaten signiﬁcantly both human and animal
health. In the last hundred years, several inﬂuenza pandemics were
responsible for the deaths of at least 40 million people (Horimoto and
Kawaoka, 2005). Recently, a highly pathogenic avian inﬂuenza virus
(AIV; H5N1) has resulted in the death ofmore than 200 people and the
slaughter of millions of poultry in Asia, Europe and Africa, raising
concern over the possibility of a new inﬂuenza pandemic among the
world's immunologically naive populations (Horimoto and Kawaoka,
2005).
The virus belongs to the Orthomyxoviridae family and contains
eight segments of single-stranded RNA (ssRNA) which encode 11
proteins, PB2, PB1, PB1-F2, PA, HA, NP, NA, M1, M2, NS1 and NS2
(Nelson and Holmes, 2007). These segments allow for the swapping
and exchange of gene segments between different strains. Speciﬁcally
it occurs when the human inﬂuenza viruses swap their HA
glycoprotein, NA glycoprotein or polymerase (PB1, PB2, PA) segments
with those of avian and pig Inﬂuenza A viruses. Although the origin of
the H1N1 strain that caused the severe pandemic of 1918 is less clear
and the source of much debate (Antonovics et al., 2006; Gibbs and
Gibbs, 2006; Taubenberger et al., 2005), reassortment among HA and
NA subtypes was fundamental in the human pandemics of 1957
(H2N2 subtype) and 1968 (H3N2 subtype), which also acquired a new
basic polymerase 1 (PB1) segment (Lindstrom et al., 2004).ed at College of Life Science,
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amino acid mutation. Dynamic gene mutant has been shown to play
an important role in the virulence change of AIV (Hatta et al., 2001;
Hulse-Post et al., 2007), but homologous recombination also plays an
important role in the evolution of some RNA viruses (Kirkegaard and
Baltimore, 1986; Lai, 1992; Nagy and Simon, 1997). Virulent variants of
some other viruses have been generated by homologous recombina-
tion (Anderson et al., 2000; Kew et al., 2002; Pita et al., 2001;Worobey
et al., 1999). For inﬂuenza A virus, there has been ample evidence that
inﬂuenza viruses undergo various forms of non-homologous recom-
bination. For example, a recombination can occur between HA and
nucleoprotein gene (Orlich et al., 1994). Similarly, increased viral
pathogenicity after insertion of a 28S ribosomal RNA sequence into the
haemagglutinin gene of an inﬂuenzaviruswas also found (Khatchikian
et al., 1989). However, the occurrence of homologous recombination
within segments is far from proven (Nelson and Holmes, 2007).
In order to clarify whether homologous recombination drives the
evolution of human inﬂuenza A, we analyzed the H1N1 subtype of
about 3800 genes and found several signiﬁcant evidences of recombi-
nationbetween swineH1N1andhumanH2N2 subtypes inPA, between
swine lineage strains in PB2, and between human lineage strains in HA
and NP. Particularly, in a mosaic PA of swine H1N1, one putative parent
seems to be derived from a cold-adapted avirulent vaccine lineage of
human H2N2. These data show that the intragenic recombination can
indeed play a role in driving the evolution of inﬂuenza A virus. In
addition, the avirulent vaccine could shape the evolution of the virus
via homologous recombination with circulating inﬂuenza A virus.
Results and discussion
We performed different segment comparisons of available H1N1
subtype sequences (total 3815 complete gene segment sequences, HA,
Table 1
Inﬂuenza A virus strains with signiﬁcant evidence for recombination
No. Accession no. Mosaic virus strain Gene Putative parent lineages Breakpoint(s) pSH
1 DQ280191 A/swine/Ontario/57561/03(H1N1) PA A/swine/Ontario/55383/04(H1N2) 515 b0.001
A/Ann Arbor/6/1960(H2N2)
2 DQ280213 A/Swine/Ontario/53518/03 PB2 A/Swine/Korea/CY02/02(H1N2) 538 b0.001
A/swine/Alberta/56626/03(H1N1)
3 DQ415318 A/Taiwan/4845/99(H1N1) HA A/WSN/33(H1N1) 136, 623, 960 b0.001
A/Wellington/24/2000(H1N1)
4 AF255749 A/Hong Kong/498/97(H3N2) NP A/Hong Kong/427/98(H1N1) 223 b0.01
A/Hong Kong/497/97(H3N2)
Note. pSH indicates probability of Shimodaira–Hasegawa test.
13C.-Q. He et al. / Virology 380 (2008) 12–20485; NA, 472; PA, 459; PB1, 467; PB2, 457; M, 478; NS, 476; NP, 521) to
ﬁnd evidence of recombination between inﬂuenza A and to identify
potential breakpoints for any such events. Among 3815 complete
genes of inﬂuenza A, at least four mosaics were found (Table 1). In
particular, the natural recombinant A/swine/Ontario/57561/03(H1N1)
(DQ280191) is descended from swine H1N1 and human H2N2 in the
gene PA. The results show that the homologous recombination can
drive mammal inﬂuenza A virus evolution, and might result in
potential change of virus virulence and host tropism.
A/swine/Ontario/57561/03(H1N1)
Recently, Karasin et al. (2006) reported three novel genotypes
of H1 inﬂuenza viruses recovered from pigs in Ontario of Canada.
Reassortment between inﬂuenza viruses was found to be the cause
resulting in these novel genotypes (Karasin et al., 2006). These
viruses were isolated from pigs that ranged in age from 3-week-
old nursery piglets to adult sows and that exhibited various
clinical signs typical of swine inﬂuenza illness (Karasin et al., 2006).
Theywerepassaged nomore than once beyond initial isolation before
sequencing (Karasin et al., 2006). Their sequences were checked
multiple times and determined using multiple primer pairs to be
sure that none of the reported sequences were artifacts (personal
communication to Prof. Olsen CW). Among these viruses, A/swine/
Ontario/57561/03(H1N1) and A/swine/Ontario/53518/03(H1N1)
were suspected as intragenic recombinants in PA and PB2 segment
respectively.
We conducted a similarity analysis using A/swine/Ontario/
57561/03(H1N1) as a query. The standard similarity plot, con-
structed using all sites, reveals that the PA sequence exhibits
greater afﬁnity with the inﬂuenza A human lineage than the swine
lineage in the region from position 1 to 548 (Fig. 1A). On the
contrary, the mosaic shares higher sequence similarity with the
swine lineage than the human lineage in the region from 549 to
2147. The incongruent phylogenetic trees incorporating the avian
lineage provide a robust, informative test of the recombination
hypothesis (Worobey et al., 2002). When the maximum likelihood
trees separated by position 548 were constructed, a signiﬁcant
discrepancy (Shimodaira–Hasegawa test, pb0.001) between phylo-
genetic trees constitutes a powerful evidence for recombination in
A/swine/Ontario/57561/03(H1N1) (Figs. 1C and D).
Because two cold-adapted avirulent H2N2 vaccines, A/Ann Arbor/
6/1960(H2N2) and A/Leningrad/134/47/57(H2N2) were not included
in our data initially, we were puzzled when its putative minor parent
of the mosaic virus was identiﬁed. We found the region from
nucleotide 1 to 548 of the mosaic strain fell into the subgroup of
H2N2 isolated from 1957 to 1968 in phylogenetic tree. However, the
mosaic strain was isolated in 2003. PA gene of human H2N2 was
estimated to have evolved at rates of 2.49×10−3 ns/s/year (R2=0.92)
(Lindstrom et al., 2004). The sequence similarity between the mosaic
isolated in 2003 and the H2N2 group isolated in 1960s should be about
90%. However, we found that the mosaic shared nearly 99% sequencesimilarity with some strains isolated in 1968. It would suggest that the
putative parent of the mosaic had nearly no evolution during the
45 years when it circulated in the ﬁeld, and this could not be true. A
hypothesis would be that the minor parent has been descended from
an avirulent vaccine of H2N2. In agreement, when the two vaccines A/
Ann Arbor/6/1960(H2N2) and A/Leningrad/134/47/57(H2N2) were
incorporated into the phylogenetic trees, the mosaic strain came
forth in the lineage of H2N2 vaccines (Fig. 1C). The avirulent vaccine A/
Ann Arbor/6/60 shares the highest sequence similarity (99.45%, 543/
546) with the mosaic strain from position 1 to 546 among all isolates
deposited in the GenBank. A CAIV-T (tradename FluMistTM, Aviron,
Mt. View, CA) derived from A/Ann Arbor/6/60 (Gruber, 2002;
Herlocher et al., 1993) has been licensed in the US since 2003,
suggesting that it might be shed by the vaccinees in the Ontario region
and act as the putative minor parent of the mosaic. Therefore, we
proposed that the putative minor parent of the mosaic might have
descended from the lineage of the avirulent vaccine of human H2N2.
This ﬁnding also suggested that the avirulent vaccine of human
inﬂuenza A was able to shape the genetic diversity of the virus via
homologous recombination with circulating viruses.
After the putative parents were identiﬁed, further recombination
analyses were carried out to determine the potential breakpoints. A
single breakpoint was located in a parsimonious region from 511–542
with the maximization of χ2 using the program SimPlot. The most
likely breakpoint was found exactly at site 515 according to Single
Breakpoint Analysis in GARD (Figs. 1E–H).
A/swine/Ontario/53518/03(H1N1)
In a previous study, A/Swine/Ontario/53518/03 was found to be a
human–swine reassortant in PB1 that exhibited various clinical signs
typical of swine inﬂuenza illness (Karasin et al., 2006). It is very
interesting that its PB2 is also an intragenic mosaic (Fig. 2).
We conducted a similarity analysis using A/Swine/Ontario/53518/
03 as a query. The standard similarity plot reveals that the PB2
sequence exhibits greater afﬁnity with the swine inﬂuenza A virus
H1N1 subgroup than the H1N2 subgroup from position 1 to 537 (Fig.
1A). On the contrary, the mosaic shares higher sequence similarity
with the swine H1N2 subgroup than the H1N1 subgroup from
position 537 to 2273. A signiﬁcant discrepancy between phylogenetic
trees inferred for nucleotide sequences of each recombination region
was found (Shimodaira–Hasegawa test, pb0.001) when themaximum
composite likelihood trees were constructed incorporating the human
lineage (Figs. 2B–D). These results constitute powerful evidences for
PB2 mosaic in A/swine/Ontario/57561/03(H1N1) descended from
swine H1N1 and H1N2 inﬂuenza A virus.
To ﬁnd the putative parents of A/Swine/Ontario/53518/03, we
performed BLAST using PB2 of A/Swine/Ontario/53518/03 as a query
in the GenBank and found that A/swine/Alberta/56626/03 shared the
highest sequence similarity with the mosaic gene from position 1
(initial code) to 537. Interestingly, an isolate from Korea A/Swine/
Korea/CY02/02 shared the highest sequence similarity with the
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Fig. 1. The evidences for recombination in PA gene of the strain A/swine/Ontario/57561/03(H1N1). A, PA similarity from SimPlot analysis of A/swine/Ontario/57561/03(H1N1) is
shown. Comparison of inﬂuenza A strain A/swine/Ontario/57561/03(H1N1) with the swine and human inﬂuenza A strains. The y-axis gives the percentage of similarity within a
sliding window of 200 bp wide centered on the position plotted, with a step size between plots of 20 bp. B–D, phylogenetic trees for PA genes. The relationships of nucleotide
sequences of the PA gene derived from humans, pigs and birds are indicated by an unrooted tree constructed using the ML method, implemented in the Phyml as described in
Methods. The values of bootstrap are shown below or above the branch, respectively. The scale corresponds to the number of nucleotide substitutions per site in all trees. Only
bootstrap values more than 70% are shown on each branch. The GenBank number of each segment is also listed after its name. B, the phylogenetic tree of complete PA ORF. C, the
phylogenetic tree of the region from position 1 to 548. D, the phylogenetic tree of the region from position 549 to 2147. E–H, identiﬁcation of recombination breakpoints in detail. E,
similarity plot as in Fig. 1A with a window size of 200 bp and a step size of 20 bp. Vertical lines indicate the breakpoint identiﬁed by maximization of χ2 and sample Akaike
Information Criterion as described in Methods. Comparison of the strain A/swine/Ontario/57561/03(H1N1) with putative parents A/Ann Arbor/6/60 and A/swine/Ontario/55383/04
(H1N2) is shown in E. The rest is the same as Fig. 1A. F, the result of Bootscaning. The y-axis gives the percentage of permutated trees using a sliding window of 200 bp wide centered
on the position plotted, with a step size between plots of 20 bp. DE-R49/99 was used as the outgroup to determine the breakpoints. G and H are the ML phylogenies inferred for the 2
regions delimited by the informative-site analysis as described in Methods.
15C.-Q. He et al. / Virology 380 (2008) 12–20mosaic from nt 537 to 2273. This suggested the existence of a global
reservoir of inﬂuenza A virus. Therefore, we proposed that the two
strains might be the putative parents of the mosaic. The comparisons
between the mosaic and its putative parents are shown in Figs. 2E and
F. A breakpoint, from position 537 to 540 was found in PB2 gene of A/
swine/Ontario/53518/03(H1N1) by maximization of χ2 and Findsites
sub-program of Simplot Program. And running the GARD online, the
exact breakpoint was located in position 538. The mosaic PB2 shares
100% sequence similarity with A/swine/Alberta/56626/03 (versus
84.34% with A/Swine/Korea/CY02/02) from nt 1 to 538. However,
from nt 539 to 2237, it also shares 99.89% sequence similarity with A/
Swine/Korea/CY02/02 (versus 82.86% with A/swine/Alberta/56626/03). These analyses determined further that the PB2 of A/swine/
Ontario/53518/03 is an intragenic recombinant.
In this study, we analyzed 3815 segment sequences of mammalian
inﬂuenza A virus (equal to about 440 complete genomes) and only
found 4 mosaic strains (Table 1). It means that the frequency of
intragenic recombination is not high in mammalian inﬂuenza A virus.
However, intragenic recombination happens indeed between differ-
ent or same subtype viruses; although the recombination has always
been ignored in inﬂuenza A virus. Recombination, like point mutation
and reassortment, can also produce novel virus variants and results in
increased virulence (Anderson et al., 2000; Kew et al., 2002; Worobey
et al., 1999). Here, we ﬁnd that recombination can occur in PB2 and PA,
Fig. 1 (continued).
16 C.-Q. He et al. / Virology 380 (2008) 12–20HA (between human H1N1 subtype strains) and NP (between human
H1N1 subtype strain and H3N2 subtype strain) (Table 1). The
virulence of inﬂuenza A viruses is associated with their HA (Horimoto
and Kawaoka, 1994; Perdue et al., 1997; Senne et al., 1996). Mutations
in the HA gene have produced highly pathogenic strains, and the
major pandemics of 1957 and 1968 might be largely caused by the
introduction of antigenically novel HA genes from bird-infecting
inﬂuenzas (Khatchikian et al., 1989; Subbarao et al., 1998). Addition-
ally, the polymerase complex genes were also found to contribute to
the high virulence of the human H5N1 inﬂuenza virus (Salomon et al.,
2006). And PB2 mutation is responsible for the virulence change in
AIV (Hatta et al., 2001). If recombination happens in genes responsibleFig. 2. The evidences for recombination in PB2 gene of the strain A/swine/Ontario/53518/03(H
with all swine inﬂuenza A strains listed in Fig. 2B. The y-axis gives the percentage of identity w
between plots of 20 bp. B, ML phylogenetic tree for full-length open reading frame (ORF) of P
And the rest is the same as Fig.1B. C, the phylogenetic tree of the region from position 1 to 538
comparison of the mosaic strain with its putative parents, A/swine/Alberta/56626/03(H1N
breakpoints with the maximization of χ2. F, bootscanning of PB2 of the mosaic and its parent
wide centered on the position plotted, with a step size between plots of 20 bp. The strain A/for virulence and host tropism, its potential effect on the change of
virulence and host tropism might be fatal.
Reassortment and recombination processes will allow some
viruses to acquire many of the key adaptive mutations in a single
step and hencemake amajor leap in ﬁtness space (Kuiken et al., 2006),
which might result in a change of host tropism of the virus. A
reassortment of gene segments between pig and human inﬂuenza
virus has occurred creating an entirely novel Inﬂuenza A virus strain
capable of infecting humans (Steinhauer and Skehel, 2002), and might
result in a population that is entirely immunologically naive to these
novel viruses in human being (Russell and Webster, 2005). Similarly,
the intragenic recombination between inﬂuenza virus swine lineage1N1). A, comparison of PB2 of inﬂuenza Avirus strain A/swine/Ontario/53518/03(H1N1)
ithin a sliding window of 200 bpwide centered on the position plotted, with a step size
B2 incorporating the human lineage. The tree was constructed as described in Methods.
. D, the phylogenetic tree of the region from position 539 to 2273. E, sequence similarity
1) and A/Swine/Korea/CY02/02(H1N2). The red vertical line shows the recombination
s. The y-axis gives the percentage of permutated trees using a sliding window of 200 bp
Memphis/3/1983(H1N1) was used as outgroup. The rest is the same as E.
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Fig. 2 (continued).
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19C.-Q. He et al. / Virology 380 (2008) 12–20and human lineage is also capable of creating a novel swine lineage
virus readily adaptable to human hosts. Especially, the recombination
occurring in polymerase complex between human and swine
inﬂuenza A virus might more easily result in a novel virus adapting
to human since the viral heterotrimeric polymerase complex is
considered having a role in host speciﬁcity (Gabriel et al., 2005;
Taubenberger et al., 2005). Therefore, the possibility of a recombina-
tion event triggering a pandemic by altering gene structure or
function and/or by permitting the virus to switch hosts from some
other mammal into humans should not to be neglected.
Live vaccine derived from an A/Leningrad/134/47/57 (H2N2)
master strain, a cold-adapted H2N2 strain (Rudenko et al., 1993), has
been used in Russia and other countries. Avirulent vaccine CAIV-T
(tradename FluMistTM, Aviron, Mt. View, CA) derived from A/Ann
Arbor/6/60 has been licensed in the US. The advent of live attenuated
cold-adapted inﬂuenza virus vaccine (CAIV-T) administered intrana-
sally may provide a convenient and effective alternative approach for
inﬂuenza immunization (Gruber, 2002). However, since live vaccine
strains are potentially released into the environment by vaccinees,
safety issues concerning medical as well as environmental aspects
must be considered. An important aspect concerns the exchange of
genetic information between the vaccine of interest and another
vaccine or wild-type strains of the carrier organism. Here, we found
the natural recombinant which might be derived from a live vaccine
strain. It suggests that live avirulent vaccine can play some and
perhaps a very important role in speeding up the evolution of
inﬂuenza A virus. It has been reported that a mosaic bovine viral
diarrhea virus between a persisting pestivirus and a vaccine strainwas
a cytopathogenic virus that induced lethal diseases (Becher et al.,
2001). And there have been recent polio epidemics in Hispaniola that
arose from similar recombinants involving vaccine virus and other
endogenous enteroviruses, which threatens the entire WHO polio
eradication program (Kew et al., 2002). Therefore, it might be
necessary to evaluate the effect of various vaccine recombination on
inﬂuenza A virus virulence and host tropism. From an environmental
perspective, inactivated inﬂuenza A vaccine should be safer.
In conclusion, our study provided powerful evidence that intra-
genic recombination occurs in mammalian inﬂuenza A viruses from
different species, which shows that homologous recombination may
play a role in driving the evolution of mammalian inﬂuenza A viruses
and has the potential to change their virulence and host tropism.
Finally, our results suggest that live vaccine is capable of speeding up
viral evolution via recombination with circulating viruses.
Methods
We collected all the H1N1 subtype genes (total 3815 complete
gene sequences, HA, 485; NA, 472; PA, 459; PB1, 467; PB2, 457;M, 478;
NS, 476; NP, 521) that are deposited in the GenBank and analyzed their
homologous recombination in the study. Multialignment was ﬁnished
by using CLUSTALW (Thompson et al., 2003). Gaps were removed
before further analyses were carried out. The neighbor-joining (NJ)
phylogenetic tree was generated using the maximum composite
likelihood (MCL) model implementing Mega4 (Tamura et al., 2007).
Maximum Likelihood trees were also constructed to determine the
recombination events using Phyml online tool (Guindon and Gascuel,
2003) (http://atgc.lirmm.fr/phyml/). The trees were tested using
bootstrap (1000 replications). Putative recombinant sequences were
identiﬁed with the SimPlot program (Lole et al., 1999). Shimodaira–
Hasegawa test was implemented to prove whether phylogenetic trees
estimated from different regions are signiﬁcantly different employing
Treetest program (http://aix1.uottawa.ca/∼sarisbro/). The putative
parents were searched using putative mosaic as a query by BLAST in
the GenBank. Recombination breakpoints were analyzed by max-
imization of χ2 using SimPlot combined with Akaike Information
Criterion (AIC) (AICc) (Kosakovsky Pond et al., 2006). The recombina-tion eventswere also further analyzed using GARD (Genetic Algorithm
Recombination Detection) online (http://www.datamonkey.org/
GARD/) (Kosakovsky Pond et al., 2006).
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